Business
Dr Keith Layden to become a Non-Executive Director
Dr Keith Layden to become a Non-Executive Director.
About this update from Croda International Plc
[{"type":"text","content":"\n \nRNS Number : 9914X Croda International PLC 28 February 2017 \n\n28 February 2017\nCroda International Plc\n \nBoard Change\n \nDr Keith Layden to become a Non-Executive Director\n \nCroda International Plc ('Croda' or 'the Company') today announces that Dr. Keith Layden, (57) Chief Technology Officer and President, Life Sciences, has decided to retire from the Company after 32 years of service. Keith has accepted the Board's invitation to continue as a Non-Executive Director and help guide Croda's highly successful innovation agenda further forward.\n \nDr. Nick Challoner, President, Asia, will also become President of Life Sciences and lead Croda's Global Research and Technology function.\n \nThese changes will take effect from 1 May 2017.\n \nAnita Frew, Chairman, said:\n\"I would like to thank Keith for his long service and exceptional contribution to Croda. I am delighted that the Board will continue to have the benefit of Keith's unparalleled expertise in technology and innovation.\"\nSteve Foots, Chief Executive Officer, said:\n\"Keith is one of the principal architects for Croda becoming the successful business that it is today. Under his direction, Croda has significantly expanded its R&D capability and introduced impactful new technologies to the market. I would like to thank him for over three decades of service and for being a huge inspiration to so many people at Croda and across our industry. We look forward to the enormous value that he will bring to Croda as a Non-Executive Director.\"\n \n \n \nFor enquiries contact:\n \nCroda: Conleth Campbell, VP Investor Relations +44 1405 860551\nTeneo Blue Rubicon: Charlie Armitstead +44 20 3603 5220\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END BOAEANAXADNXEFF\n ","length":2593,"tagName":"div"}]